
Hexagon Nutrition IPO
- Issue price
- ₹45
- Listing price
- ₹48.25
- +7.22%
- Current price
- ₹58.49
- +29.98%
- Subscribed
- 53.68x
- Issue size
- ₹138.87 Cr
- Listed on
- 12 Jun 2026
IPO timeline
- Opens5 JunFri
- Closes9 JunTue
- Allotment10 JunWed
- Refunds11 JunThu
- Demat credit11 JunThu
- Listing12 JunFri
Issue details
- Price band
- ₹42 – ₹45 per share
- Issue size
- ₹138.87 Cr
- Fresh issue
- Not available
- Offer for sale
- Not available
- Issue type
- book build issue
- Face value
- ₹1 per share
- Lot size
- 333 shares
- Minimum investment
- ₹14,985
- Listing on
- BSE, NSE
- Exchange code
- HEXAGON.BO · 7752
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 333 | ₹14,985 |
| Retail (Max) | 13 | 4,329 | ₹1,94,805 |
| S-HNI (Min) | 14 | 4,662 | ₹2,09,790 |
| B-HNI (Min) | 67 | 22,311 | ₹10,03,995 |
Reservation
- QIB
- 1,54,29,851 shares (50.00% of the Offer)
- NII
- 46,28,956 shares (15.00% of the Offer)
- Retail
- 1,08,00,897 shares (35.00% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on KFin Technologies- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 10 Jun 2026
- Refunds initiated
- 11 Jun 2026
- Shares credited to demat
- 11 Jun 2026
- Listing
- 12 Jun 2026
Grey market premium (GMP)
- Current GMP
- ₹2.75
- +6.10%
- Estimated listing price
- ₹47.75
- Issue price ₹45
- Highest
- ₹12
- 5 Jun
- Lowest
- ₹0
- 26 May
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 12 Jun 2026 | ₹2.75 | +6.10% | ₹47.75 |
| 9 Jun 2026 | ₹3.5 | +8.00% | ₹48.5 |
| 8 Jun 2026 | ₹6.5 | +14.00% | ₹51.5 |
| 6 Jun 2026 | ₹11.75 | +26.00% | ₹56.75 |
| 5 Jun 2026 | ₹12 | +27.00% | ₹57 |
| 4 Jun 2026 | ₹11.5 | +26.00% | ₹56.5 |
| 3 Jun 2026 | ₹0 | — | ₹45 |
| 2 Jun 2026 | ₹0 | — | ₹45 |
| 29 May 2026 | ₹0 | — | ₹45 |
| 27 May 2026 | ₹0 | — | ₹45 |
| 26 May 2026 | ₹0 | — | ₹45 |
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB19.77x
- NII (HNI)161.49x
- Retail26.85x
| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 61,72,155 | 12,20,36,508 | 19.77x |
| Non-Institutional Investors (NII) | 46,28,956 | 74,75,41,377 | 161.49x |
| bNII — bids above ₹10 Lakh | 30,85,971 | 56,52,31,203 | 183.16x |
| sNII — bids ₹2 Lakh to ₹10 Lakh | 15,42,985 | 18,23,10,174 | 118.15x |
| Retail Individual Investors (RII) | 1,08,00,897 | 29,00,31,012 | 26.85x |
| Total | 2,16,02,008 | 1,15,96,08,897 | 53.68x |
Financials
- P/E Ratio
- 15.35
- EPS (₹)
- 2.93
- RoE
- 13.02%
- RoCE
- 14.82%
- RoNW
- 12.12%
- PAT Margin
- 9.81%
- EBITDA Margin
- 14.03%
- Debt / Equity
- 0.18
- NAV (₹)
- 18.15
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 275.57 | 331.29 | 304.62 |
| OPM % | |||
| EBITDA | 37.55 | 40.0724.88 | |
| Net Profit | 27.03 | 24.38 | 12.21 |
| Debt | 39.79 | 26.60 | 36.89 |
| Assets | 327.60 | 261.36 | 250.54 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Hexagon Nutrition This IPO | ₹138.87 Cr | 15.35 | 12.12% | 9.81% | 53.68x | +7.22% |
| Kronox Lab Sciences Mainboard · listed 10 Jun 2024 | ₹130.15 Cr | 24.47 | 25.66% | 22.60% | 117.25x | +21.29% |
| Amanta Healthcare Mainboard · listed 9 Sep 2025 | ₹126 Cr | 46.59 | 10.89% | 3.86% | 82.6x | +7.14% |
| Anlon Healthcare Mainboard · listed 3 Sep 2025 | ₹121.03 Cr | 23.57 | 25.51% | 17.06% | 7.12x | +1.10% |
| Gaudium IVF Mainboard · listed 27 Feb 2026 | ₹165 Cr | 22.99 | 41.71% | 26.96% | 7.27x | +5.06% |
| Gujarat Kidney & Super Speciality Mainboard · listed 30 Dec 2025 | ₹250.8 Cr | 61.62 | 36.61% | 23.61% | 5.21x | +5.26% |
| Sai Parenteral's Mainboard · listed 2 Apr 2026 | ₹409 Cr | 72.19 | 5.09% | 8.93% | 1.08x | +2.04% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Hexagon Nutrition plans to use the money raised, as stated in the offer document.
About Hexagon Nutrition
Hexagon Nutrition was incorporated in 1993 and is engaged in the nutrition and healthcare industry with a focus on micronutrient formulations and wellness products. The company was founded by the late Shri Vinod D. Shah and is currently promoted by the Shah family. Over the years, Hexagon Nutrition has built a strong presence in clinical nutrition, therapeutic nutrition, food fortification, and preventive healthcare solutions. The company operates manufacturing facilities in India and overseas while serving customers across domestic and international markets. The company offers a wide range of products including micronutrient premixes, vitamin and mineral blends, protein supplements, ready-to-use therapeutic foods, and clinical nutrition products. Hexagon Nutrition follows a diversified business model catering to both B2B and B2C segments, supplying nutritional ingredients to food and pharmaceutical companies while also selling branded healthcare products. Its strong research and development capabilities, export network across multiple countries, and focus on affordable nutrition solutions have helped the company expand its market presence globally.
Strengths
- Strong presence in clinical nutrition and micronutrient premix segment.
- Exports products to over 70 countries across global markets.
- Diversified product portfolio reduces dependence on single category revenue.
- Experienced promoter family with long operational industry expertise.
- Focus on research-driven and affordable nutrition healthcare solutions.
Risks
- Raw material price fluctuations may impact operating profit margins.
- High competition from established domestic and multinational nutrition companies.
- Business depends heavily on regulatory approvals and compliance standards.
- Export revenue exposure creates foreign currency fluctuation risks.
- Dependence on healthcare and nutrition demand trends for growth.
Promoters and shareholding
Arun Purushottam Kelkar, Nikhil Arun Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar
- Shares outstanding, pre-issue
- 89.41
- Shares outstanding, post-issue
- 64.29
Registrar, lead managers and documents
Company contact
404 Global Chamber Adarsh Nagar Link Road Andheri (W) Mumbai, Maharashtra, 400053
+91 22 6213 6710
cs.hnpl@hexagonnutrition.comDocuments
Hexagon Nutrition IPO: common questions
1.When does the Hexagon Nutrition IPO open and close?
The Hexagon Nutrition IPO opens on 5 Jun 2026 and closes on 9 Jun 2026.
2.What is the price band of the Hexagon Nutrition IPO?
The price band is ₹42 – ₹45 per share, with a lot size of 333 shares and a minimum investment of ₹14,985.
3.What is the size of the Hexagon Nutrition IPO?
The issue size is ₹138.87 Cr (book build issue).
4.What is the GMP of the Hexagon Nutrition IPO?
The last reported grey market premium is ₹2.75 per share as of 12 Jun 2026, 08:59 PM IST. GMP is unofficial and changes frequently.
5.When is the Hexagon Nutrition IPO allotment?
The basis of allotment is expected on 10 Jun 2026. Allotment status can be checked with the registrar, KFin Technologies Limited.
6.When will the Hexagon Nutrition IPO list?
The shares listed on 12 Jun 2026 on BSE, NSE.
7.Who is the lead manager of the Hexagon Nutrition IPO?
The book running lead managers are Cumulative Capital Pvt. Ltd., Catalyst Capital Partners Private Limited, and the registrar is KFin Technologies Limited.
8.How can my company launch an IPO like Hexagon Nutrition?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393